Niki BioSolutions, Inc. (NIKI) Long-Term Investments (2017 - 2023)

Niki BioSolutions (NIKI) has 7 years of Long-Term Investments data on file, last reported at $16.1 million in Q4 2023.

• Quarterly Long-Term Investments rose 65.2% year-over-year to $16.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $16.1 million (up 65.2% YoY) and the FY2025 annual result came in at $15.1 million, changed 0.0% from the prior year.
• Long-Term Investments improved to $16.1 million in Q4 2023, from $9.7 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $101.2 billion in Q2 2020 to a low of $425916.0 in Q2 2019.
• A 5-year average of $19.3 billion and a median of $9.7 million in 2022 frame the typical range for Long-Term Investments.
• The widest YoY moves for Long-Term Investments: up 23768201.73% in 2020, down 100.0% in 2020.
• Tracing NIKI's Long-Term Investments over 5 years: stood at $87.6 billion in 2019, then plunged by 100.0% to $4.1 million in 2020, then rose by 1.89% to $4.2 million in 2021, then soared by 134.43% to $9.7 million in 2022, then jumped by 65.2% to $16.1 million in 2023.
• The last three Long-Term Investments figures came in at $16.1 million (Q4 2023), $9.7 million (Q2 2023), and $9.7 million (Q4 2022), per Business Quant data.